止血剂市场－全球产业规模、份额、趋势、机会和预测，按类型、剂型、应用地区和竞争格局划分，2020-2030年预测

2024年全球止血剂市场规模为38.2亿美元，预计2030年将以7.48%的复合年增长率成长至58.9亿美元。止血剂是一种特殊的医疗器材或製剂，用于在外科手术、创伤或其他各种医疗情况下止血，其作用机制是透过促进凝血或提供机械屏障。全球止血剂市场成长的主要驱动因素包括：全球外科手术量不断增加、全球人口老化加剧导致更多慢性疾病患者需要接受手术治疗，以及创伤病例的日益增加。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球止血剂市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 依类型（凝血酶型止血剂、氧化再生纤维素型止血剂、复方止血剂、明胶型止血剂、胶原蛋白型止血剂、其他止血剂）
  • 依剂型分类（基质和凝胶止血剂、片状和垫状止血剂、海绵止血剂、粉末止血剂）
  • 依应用领域（骨科手术、一般外科手术、神经外科手术、心血管外科手术、重建外科手术、妇科手术、其他外科手术应用）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美止血剂市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲止血剂市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区止血剂市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲止血剂市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美洲止血剂市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球止血剂市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc
• B Braun Medical Inc
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic Plc
• Hemostasis, LLC
• Stryker Corporation
• Integra LifeSciences Corporation

第十六章：策略建议

第17章调查会社について・免责事项

The Global Hemostats Market, valued at USD 3.82 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 5.89 Billion by 2030. Hemostats are specialized medical devices or agents employed to arrest bleeding during surgical procedures, traumatic injuries, or in various medical conditions by promoting coagulation or providing a mechanical barrier. The global hemostats market growth is principally driven by an escalating volume of surgical interventions worldwide, a progressively aging global population prone to various chronic diseases requiring surgical treatment, and the rising incidence of trauma cases.

Key Market Drivers

The Global Hemostats Market is significantly influenced by the confluence of a growing geriatric population and continuous advancements in hemostatic technologies. The increasing proportion of older adults globally represents a substantial and expanding patient demographic requiring surgical intervention. This demographic often presents with multiple comorbidities, necessitating more frequent and complex procedures where effective bleeding control is paramount. For instance, according to a study highlighted by ResearchGate in August 2025, older individuals typically require surgical procedures four times more often than the younger population, directly increasing the demand for hemostatic agents during these interventions.

Key Market Challenges

The stringent and complex regulatory approval processes represent a significant impediment to the growth of the Global Hemostats Market. These rigorous requirements necessitate protracted development timelines and substantially increased costs for manufacturers. Such an environment diverts significant financial and human capital towards compliance rather than innovation, thereby slowing the introduction of novel hemostatic solutions to address unmet clinical needs.

Key Market Trends

The expanding adoption of minimally invasive surgical approaches significantly influences the global hemostats market by creating demand for specialized bleeding control solutions. These techniques, favored for enhanced patient recovery and reduced hospital stays, are increasingly applied across diverse surgical disciplines. According to the National Institutes of Health, over 1 million hip and knee arthroplasty procedures were performed annually in the U. S. in 2024, a large volume where minimally invasive techniques are increasingly utilized. This procedural shift necessitates hemostatic agents that are effective and precisely applicable within constricted surgical fields.

Key Market Players

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc
• B Braun Medical Inc
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic Plc
• Hemostasis, LLC
• Stryker Corporation
• Integra LifeSciences Corporation

Report Scope:

In this report, the Global Hemostats Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemostats Market, By Type:

• Thrombin-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Combination Hemostats
• Gelatin-based Hemostats
• Collagen-based Hemostats
• Other Hemostats

Hemostats Market, By Formulation:

• Matrix & Gel Hemostats
• Sheet & Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Hemostats Market, By Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Other Surgical Applications

Hemostats Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hemostats Market.

Available Customizations:

Global Hemostats Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemostats Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Other Hemostats)
  • 5.2.2. By Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats)
  • 5.2.3. By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Surgical Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Hemostats Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Formulation
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hemostats Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Hemostats Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Hemostats Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Application

7. Europe Hemostats Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Formulation
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hemostats Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Application
  • 7.3.2. France Hemostats Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Hemostats Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Hemostats Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Hemostats Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Application

8. Asia Pacific Hemostats Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Formulation
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hemostats Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Application
  • 8.3.2. India Hemostats Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Hemostats Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Hemostats Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Hemostats Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Application

9. Middle East & Africa Hemostats Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Formulation
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hemostats Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Hemostats Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Hemostats Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Application

10. South America Hemostats Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Formulation
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hemostats Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Hemostats Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Hemostats Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hemostats Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Johnson & Johnson
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Baxter International Inc.
• 15.3. Pfizer Inc
• 15.4. B Braun Medical Inc
• 15.5. Becton, Dickinson, and Company
• 15.6. Teleflex Incorporated
• 15.7. Medtronic Plc
• 15.8. Hemostasis, LLC
• 15.9. Stryker Corporation
• 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer